03/20 Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against LogicBio Therapeutics, Inc.
To join this class action, please complete the following Investor Certification. [contact-form-7 id=”1488″ title=”LogicBio Therapeutics, Inc. (NASDAQ: LOGC) Investor Certification”] Oklahoma City, OK (March 20, 2020) – On March 18, 2020, a securities class action lawsuit was filed in the United States District Court for the District of New Jersey against LogicBio Therapeutics, Inc. (NASDAQ: LOGC). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the […]